Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation.

Area of Science:

• Biochemistry
• Pharmacology
• Cardiovascular Research

Background:

• Phospholipase D (PLD) isoforms, PLD1 and PLD2, are implicated in thrombotic events.
• Previous studies showed differential effects of PLD1 and PLD2 inhibitors on human vs. mouse platelet aggregation.
• The precise role of PLD1 and PLD2 in mouse thrombosis and stroke remains unclear.

Purpose of the Study:

• To investigate the role of PLD1 and PLD2 in acute pulmonary thrombosis and ischemic stroke in mice.
• To evaluate the therapeutic potential of selective and combined PLD1/PLD2 inhibition in these conditions.

Main Methods:

• Utilized selective inhibitors for PLD1 and PLD2 in mouse models.
• Assessed outcomes in acute pulmonary thrombosis and transient middle cerebral artery occlusion models.
• Evaluated survival rates, infarct size, brain edema, and neurological function tests (e.g., rotarod, open field).

Main Results:

• PLD1 inhibition partially prevented mortality in pulmonary thrombosis.
• Concurrent PLD1 and PLD2 inhibition significantly increased survival rates.
• PLD1 inhibition alone offered partial protection against ischemic stroke, with combined inhibition showing enhanced neuroprotection.
• Neuroprotection was evidenced by reduced infarct volume, brain edema, and improved neurological scores.

Conclusions:

• PLD1 plays a more critical role than PLD2 in mouse thrombosis and stroke models.
• PLD1 and PLD2 exhibit synergistic or partially redundant functions in regulating thrombosis-related events.
• Combined inhibition of PLD1 and PLD2 presents a promising therapeutic strategy for thrombotic and ischemic conditions.